Acorda Therapeutics, Inc.
Acorda Therapeutics Reports Second Quarter 2009 Financial Results
Published in Healthcare Finance, Tax and Law Weekly, August 19th, 2009
"A very productive second quarter was highlighted by the completion of our ex-U.S. collaboration with Biogen Idec, which we believe could benefit people with MS as well as Acorda shareholders. Biogen Idec has the capabilities and expertise to maximize the value of Fampridine-SR in ex-US markets, if approved, and to make it available to patients around the world who can potentially benefit from it," said Ron Cohen, M.D., Acorda Therapeutics' President and CEO. "To continue to build shareholder value, in addition to advancing the Fampridine-SR program we are moving two...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- 99¢ Only Stores
99¢ Only Stores(R) Announces It Will Continue to Operate in Texas and Cancels Plan to Exit Texas Market - A123Systems
A123Systems Awarded $249M Grant from U.S. Department of Energy to Build Advanced Battery Production Facilities in the United States - AARP New York
AARP Responds to Health Reform Scare Tactics - Acacia Research Corporation
Acacia Subsidiary Enters into Licensing Agreement with Xerox Corp. - Accountemps
Survey: Approximately One-Quarter of Executives Say Their Companies Scaled Back Professional Development in Last 12 Months - Acorda Therapeutics, Inc.
Acorda Therapeutics Names Ruhi Kahn as Vice President, Business Development - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
